Efficacy of acarbose with metformin and myo-inositol in dual combo therapy may enhance cardio-metabolic safety in PCOS: Study Medha Baranwal16 July 2024 8:15 PM ISTIndia: A recent randomized controlled trial has shed light on the effectiveness of dual combination therapies involving acarbose, metformin, and...
Microvascular complications of diabetes linked to pancreatic cancer Dr. Kamal Kant Kohli5 Dec 2022 10:00 AM ISTCHINA: According to a study published in the Journal of the Endocrine Society, early-stage chronic kidney disease, a microvascular complication of...
Acarbose best suited for newly diagnosed type 2 diabetes patients with obesity Dr Kartikeya Kohli2 Nov 2022 12:00 PM ISTChina: Acarbose is the first glucosidase inhibitor used in the clinical therapy of type 2 diabetes mellitus (T2DM). The mode of action is that it may...
Novel combination of orlistat and acarbose promising for effective weight loss among obese adults Dr Kartikeya Kohli18 Oct 2022 12:00 PM ISTSweden: A novel, oral, modified-release formulation containing Orlistat and acarbose (EMP16) is compelling for weight loss with no unexpected safety...
Acarbose and metformin normalize blood sugar in patients with impaired glucose tolerance: Study Medha Baranwal10 Nov 2021 9:00 AM ISTChina: Acarbose and metformin are associated with reduced rates of progression to diabetes and increased rates of achieving normal blood sugar levels...
